A commensal-derived sugar protects against obesity by regulating immunometabolism
Cell Host & Microbe · 2026-11 · 34 (11) · 2195-2210.e7
DOI: 10.1016/j.chom.2026.08.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Host & Microbe, 2026-11. Verfasst von Chin Yee Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke Universi…. Hauptthemen laut MEDLINE: Obesity, Polysaccharides, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases.
Abstract (Originalsprache)
Obesity is a worsening global epidemic that is partially regulated by the microbiota through unknown factors. We discovered a human commensal bacterium, Clostridium immunis, which prevents and treats obesity in mice by secreting a phosphocholine-modified exopolysaccharide. Loss- and gain-of-function bacterial mutants involving the phosphocholine biosynthesis locus (licABC) revealed that the phosphocholine moiety is required to protect against metabolic disease. This C. immunis exopolysaccharide decreases small-intestinal and visceral fat levels of IL-22, which increases metabolic activity specifically in visceral adipose tissue; C. immunis lacks activity against obesity when IL-22 or group 3 innate lymphoid cells, predominant secretors of IL-22, are absent. Importantly, phosphocholine biosynthesis genes are less abundant in humans with obesity or hypertriglyceridemia, suggesting conserved functions of bacterial phosphocholine. These results define a bacterial molecule-and its key structural motif-that provides immunometabolic control of obesity. More broadly, they highlight a clinically translatable strategy to reduce visceral fat.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Duke-NUS Medicine Academ…
- Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.
- Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Program in Computational Biology and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA.
- Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Integrativ…
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases
- The Hartwell Foundation Corporation
- Duke-NUS Medical School
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- American Heart Association Inc
Zitieren
APA
Tan, C. Y., Li, Y., Jiang, D., Theriot, B. S., Rao, M. V., & Surana, N. K. (2026). A commensal-derived sugar protects against obesity by regulating immunometabolism. Cell Host & Microbe, 34(11), 2195-2210.e7. https://doi.org/10.1016/j.chom.2026.08.018
Vancouver
Tan CY, Li Y, Jiang D, Theriot BS, Rao MV, Surana NK. A commensal-derived sugar protects against obesity by regulating immunometabolism. Cell Host & Microbe. 2026;34(11):2195-2210.e7. doi:10.1016/j.chom.2026.08.018
BibTeX
@article{Tan2026,
author = {Tan, Chin Yee and Li, Yinghui and Jiang, Danting and Theriot, Barbara S and Rao, Meghana V and Surana, Neeraj K},
title = {A commensal-derived sugar protects against obesity by regulating immunometabolism},
journal = {Cell Host & Microbe},
year = {2026},
volume = {34},
number = {11},
pages = {2195--2210.e7},
doi = {10.1016/j.chom.2026.08.018}
}
EUVIMED